Rafael Holdings, Inc. (RFL) stock
RFLNYSEPharmaceutical PreparationsFiscal year ends July 31
$0.99+0.07 (+8.07%)
Close on Nov 18, 2026Market cap $51.51MP/E –Yield –
Rafael revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Rafael's revenue for the twelve months ending Jul 31, 2026 was $874.00K, down 4.7% year over year. For fiscal 2026 it was $874.00K, down 4.7% from the year before. Over ten years it grew -16.9% a year on average. The highest annual figure on record is $5.62M in fiscal 2017.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $874.00K | -4.7% |
| FY2025 | Jul 31, 2025 | $917.00K | +44.0% |
| FY2024 | Jul 31, 2024 | $637.00K | +128.3% |
| FY2023 | Jul 31, 2023 | $279.00K | -32.0% |
| FY2022 | Jul 31, 2022 | $410.00K | -48.9% |
| FY2021 | Jul 31, 2021 | $802.00K | -83.7% |
| FY2020 | Jul 31, 2020 | $4.91M | -0.4% |
| FY2019 | Jul 31, 2019 | $4.93M | +12.8% |
| FY2018 | Jul 31, 2018 | $4.37M | -22.2% |
| FY2017 | Jul 31, 2017 | $5.62M | +0.5% |
| FY2016 | Jul 31, 2016 | $5.59M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $244.00K | -30.3% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $179.00K | -50.6% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $211.00K | +174.0% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $240.00K | +87.5% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $350.00K | +112.1% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $362.00K | +7.7% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $77.00K | +13.2% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $128.00K | +88.2% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $165.00K | +142.6% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $336.00K | +373.2% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $68.00K | -2.9% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $68.00K | -2.9% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $68.00K | -1.4% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $71.00K | -6.6% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $70.00K | -5.4% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $70.00K | -63.4% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $69.00K | -92.9% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $76.00K | -92.3% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $74.00K | -92.3% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $191.00K | -81.9% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $969.00K | -21.9% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $990.00K | -19.1% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $959.00K | -22.4% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $1.05M | -13.0% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $1.24M | -11.6% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $1.22M | -11.1% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | $1.24M | +21.5% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | $1.21M | +6.6% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | $1.40M | +15.4% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | $1.38M | +26.0% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | $1.02M | +6.4% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | $1.14M | +2.6% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | $1.22M | -24.1% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | $1.09M | -14.7% |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $956.00K | -28.5% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | $1.11M | – |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $1.60M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | $1.28M | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $1.34M | – |
See a number that looks wrong?